WO2007026376A3 - A novel process for preparation of highly pure crystalline hydrochlorothiazide - Google Patents
A novel process for preparation of highly pure crystalline hydrochlorothiazide Download PDFInfo
- Publication number
- WO2007026376A3 WO2007026376A3 PCT/IN2006/000146 IN2006000146W WO2007026376A3 WO 2007026376 A3 WO2007026376 A3 WO 2007026376A3 IN 2006000146 W IN2006000146 W IN 2006000146W WO 2007026376 A3 WO2007026376 A3 WO 2007026376A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrochlorothiazide
- preparation
- pure crystalline
- highly pure
- novel process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
This invention relates to a process for the preparation and purification of a pure crystalline Hydrochlorothiazide with overall purity 99.9% or greater and single impurity below 0.1%. This is a two step process. In first step crude hydrochlorothiazide is prepared which is in second step purified to get highly pure crystalline hydrochlorothiazide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1017/MUM/2005 | 2005-08-29 | ||
IN1017MU2005 | 2005-08-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007026376A2 WO2007026376A2 (en) | 2007-03-08 |
WO2007026376A3 true WO2007026376A3 (en) | 2008-04-10 |
Family
ID=37809293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2006/000146 WO2007026376A2 (en) | 2005-08-29 | 2006-04-27 | A novel process for preparation of highly pure crystalline hydrochlorothiazide |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007026376A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102329283B (en) * | 2011-07-14 | 2013-08-07 | 海南锦瑞制药股份有限公司 | Hydrochlorothiazide crystal and candesartan cilexetil hydrochlorothiazide medicinal combination thereof |
CN103396381B (en) * | 2013-07-31 | 2016-06-29 | 安阳九州药业有限责任公司 | A kind of production method of hydrochlorothiazide |
CN114369073B (en) * | 2021-12-01 | 2024-03-26 | 润都制药(荆门)有限公司 | Method for preparing high-purity hydrochlorothiazide |
EP4234542A1 (en) | 2022-02-28 | 2023-08-30 | Zaklady Farmaceutyczne Polpharma S.A. | A process for manufacturing high purity hydrochlorothiazide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3163645A (en) * | 1964-09-25 | 1964-12-29 | Ciba Geigy Corp | Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides |
CH393339A (en) * | 1959-07-20 | 1965-06-15 | Simes | Process for the preparation of 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide |
-
2006
- 2006-04-27 WO PCT/IN2006/000146 patent/WO2007026376A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH393339A (en) * | 1959-07-20 | 1965-06-15 | Simes | Process for the preparation of 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide |
US3163645A (en) * | 1964-09-25 | 1964-12-29 | Ciba Geigy Corp | Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides |
Non-Patent Citations (2)
Title |
---|
DATABASE CAPLUS [online] MATSUMOTO I.: "Preparation of 5-chloro-2,4-disulfamoylaniline by the use of 1-nitro-2,4,5-trichlorobenzene", Database accession no. (1963:428557) * |
YAKUGAKU ZASSHI, vol. 83, 1963, pages 327 - 331 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007026376A2 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007149672A3 (en) | Rebaudioside a composition and method for purifying rebaudioside a | |
WO2005062897A3 (en) | Polymorphs of ezetimibe and processes for the preparation thereof | |
WO2007033383A3 (en) | Process for production of bivalirudin | |
AU2003214132A1 (en) | (meth)acrylic acid crystal and method for the production and purification of aqueous (meth)acrylic acid | |
WO2007047863A3 (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
WO2008109079A3 (en) | High purity peptides | |
WO2006024024A3 (en) | Solid and crystalline ibandronate sodium and processes for preparation thereof | |
WO2008140641A3 (en) | Pure paliperidone and processes for preparing thereof | |
WO2007026376A3 (en) | A novel process for preparation of highly pure crystalline hydrochlorothiazide | |
WO2009004643A3 (en) | An improved process for preparation of (s)-pregabalin and intermediates thereof | |
WO2009033900A3 (en) | Process for purifying polycrystalline silicon | |
WO2003011228A3 (en) | Purification and crystalline forms of zaleplon | |
AU2003293746A1 (en) | Crystalline cefdinir salts | |
WO2007002722A3 (en) | Synthesis of anastrozole and purification of one of its intermediate | |
EP1361203A3 (en) | Process for manufacturing high purity methacrylic acid | |
MX2007002808A (en) | Process for isolation of crystalline tacrolimus. | |
WO2008035380A3 (en) | An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts | |
WO2008021346A3 (en) | Pure paliperidone and processes for preparing thereof | |
WO2008139228A3 (en) | Process for the purification of olanzapine | |
WO2005030333A3 (en) | Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments | |
WO2008129077A3 (en) | Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation | |
WO2007039914A3 (en) | Novel polymorphs of telithromycin | |
WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
EP2070931A3 (en) | Process for the preparation of 2-fluoroadenine | |
WO2008034735A3 (en) | 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |
Ref document number: 06809911 Country of ref document: EP Kind code of ref document: A2 |